Immunotech Biopharm Ltd (6978.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.44B |
| Enterprise Value | 1.83B |
| P/E Ratio | -1.18 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -2.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | 3.46 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -53.87M |
| EBITDA | -168.8M |
| Net Income | -230.79M |
| Diluted EPS | -0.42 |
Balance Sheet
| Total Cash | 65.93M |
| Total Cash/Share | 0.11 |
| Total Debt | 100.71M |
| Total Debt/Equity | -1.2 |
| Current Ratio | 0.22 |
| Book Value Per Share | -0.06 |
Price History
| 52-Week Change | -91.67 |
| 52-Week High | 5.4 |
| 52-Week Low | 0.33 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 1.76 |
Statistics
| Average Volume | 236,046 |
| Shares Outstanding | 617.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
